Eledon Pharmaceuticals Inc. buy Maxi_Scalibusa
Start price
23.01.21
/
50%
€13.36
Target price
23.01.22
€100.00
Performance (%)
-77.10%
End price
24.01.22
€3.06
Summary
This prediction ended on 24.01.22 with a price of €3.06. Massive losses of -77.10% were the result for the BUY prediction by Maxi_Scalibusa. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eledon Pharmaceuticals Inc. | -9.202% | -9.202% | 13.846% | 66.292% |
| iShares Core DAX® | -1.756% | 1.667% | 2.099% | 51.746% |
| iShares Nasdaq 100 | 2.324% | 12.779% | 38.808% | 96.064% |
| iShares Nikkei 225® | 5.022% | 13.300% | 60.099% | 71.803% |
| iShares S&P 500 | 0.802% | 6.198% | 25.356% | 68.516% |
According to Maxi_Scalibusa what are the pros and cons of Eledon Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Maxi_Scalibusa for this prediction
In the thread Novus Therapeutics Inc. diskutieren
Buy mit Kursziel 100,0
In the thread Trading Novus Therapeutics Inc.
Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten


